Filtered By:
Condition: Guillain-Barr Syndrome
This page shows you your search results in order of relevance. This is page number 17.
Order by Relevance | Date
Total 314 results found since Jan 2013.
Mechanistic Episodes on SARS-CoV-2-Mediated Neurological Manifestations and Their Possible Therapeutic Interventions
J Environ Pathol Toxicol Oncol. 2022;41(1):85-98. doi: 10.1615/JEnvironPatholToxicolOncol.2021040128.ABSTRACTRecently, the emergence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has been critically recognized and spread rapidly on this planet. Considerable recognition of SARS-CoV-2 has been known with a range of viruses that are more capable to cause diseases in avian and mammals including humans. The virus was found as a main culprit for major defects in respiratory system and thereby caused severe acute respiratory syndrome disease. This has led to depict the mortality in human population. Nevertheless...
Source: Journal of Environmental Pathology, Toxicology and Oncology - April 4, 2022 Category: Environmental Health Authors: Sobia Nida Hemalatha Srinivisan Ashok Kumar Pandurangan Mohammad Waseem Source Type: research
Acute Neurologic Complications of COVID-19 and Postacute Sequelae of COVID-19
Neurologic complications can be seen in mild to severe COVID-19 with a higher risk in patients with severe COVID-19. These can occur as a direct consequence of viral infection or consequences of treatments. The spectrum ranges from non-life-threatening, like headache, fatigue, malaise, anosmia, dysgeusia, to life-threatening complications, like stroke, encephalitis, coma, Guillain-Barre syndrome. A high index of suspicion can aid in early recognition and treatment. Outcomes depend on severity of underlying COVID-19, patient age, comorbidities, and severity of the complication. Postacute sequelae of COVID-19 range from fati...
Source: Critical Care Clinics - March 22, 2022 Category: Intensive Care Authors: Neha S. Dangayach, Virginia Newcombe, Romain Sonnenville Source Type: research
Mechanistic Episodes on SARS-CoV-2-Mediated Neurological Manifestations and Their Possible Therapeutic Interventions
J Environ Pathol Toxicol Oncol. 2022;41(1):85-98. doi: 10.1615/JEnvironPatholToxicolOncol.2021040128.ABSTRACTRecently, the emergence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has been critically recognized and spread rapidly on this planet. Considerable recognition of SARS-CoV-2 has been known with a range of viruses that are more capable to cause diseases in avian and mammals including humans. The virus was found as a main culprit for major defects in respiratory system and thereby caused severe acute respiratory syndrome disease. This has led to depict the mortality in human population. Nevertheless...
Source: Journal of Environmental Pathology, Toxicology and Oncology - April 4, 2022 Category: Environmental Health Authors: Sobia Nida Hemalatha Srinivisan Ashok Kumar Pandurangan Mohammad Waseem Source Type: research
Therapeutic Approaches to the Neurologic Manifestations of COVID-19
AbstractAs of May 2022, there have been more than 527 million infections with severe acute respiratory disease coronavirus type 2 (SARS-CoV-2) and over 6.2 million deaths from Coronavirus Disease 2019 (COVID-19) worldwide. COVID-19 is a multisystem illness with important neurologic consequences that impact long-term morbidity and mortality. In the acutely ill, the neurologic manifestations of COVID-19 can include distressing but relatively benign symptoms such as headache, myalgias, and anosmia; however, entities such as encephalopathy, stroke, seizures, encephalitis, and Guillain –Barre Syndrome can cause neurologic inj...
Source: Neurotherapeutics - July 21, 2022 Category: Neurology Source Type: research
